HSBC Holdings plc (LON:HSBA – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 672.29 ($8.73) and traded as high as GBX 687.40 ($8.92). HSBC shares last traded at GBX 682.10 ($8.86), with a volume of 11,429,031 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on HSBA shares. Berenberg Bank reiterated a “buy” rating and issued a GBX 870 ($11.30) price objective on shares of HSBC in a report on Wednesday, August 21st. Citigroup reiterated a “buy” rating on shares of HSBC in a report on Monday, September 2nd. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 795 ($10.32).
HSBC Price Performance
HSBC Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, September 27th. Shareholders of record on Thursday, August 15th were paid a $0.10 dividend. The ex-dividend date was Thursday, August 15th. This represents a yield of 1.15%. HSBC’s payout ratio is 5,393.26%.
About HSBC
HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions.
Recommended Stories
- Five stocks we like better than HSBC
- How Technical Indicators Can Help You Find Oversold Stocks
- Texas Roadhouse Stock Steering for New Highs This Year
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Pros And Cons Of Monthly Dividend Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for HSBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HSBC and related companies with MarketBeat.com's FREE daily email newsletter.